Evidence for locus coeruleus-norepinephrine system abnormality in Military PTSD revealed by neuromelanin-sensitive MRI

Abstract: BACKGROUND: The complex neurobiology of post-traumatic stress disorder (PTSD) calls for the characterization of specific disruptions in brain functions that require targeted treatment. One such alteration could be an overactive locus coeruleus-norepinephrine (LC-NE) system, which may be linked to hyperarousal symptoms, a characteristic and burdensome aspect of the disorder. METHODS: Study participants were Canadian Armed Forces veterans with PTSD related to deployment to combat zones (n=34) and age-and-sex matched healthy controls (n=32). Clinical measures included the Clinician-Administered PTSD Scale for DSM-5 (CAPS-5) and neuroimaging measures included a neuromelanin-sensitive MRI scan to measure LC signal. Robust linear regression analyses related LC signal to clinical measures. RESULTS: Compared to controls, LC signal was significantly elevated in the PTSD group (t(62)=2.64, p=0.010) and this group difference was most pronounced in the caudal LC (t(56)=2.70, Cohen's d=0.72). Caudal LC signal also positively correlated to the severity of CAPS-5 hyperarousal symptoms in the PTSD group (t(26)=2.16, p=0.040). CONCLUSION: These findings are consistent with a growing body of evidence indicative of elevated LC-NE system function in PTSD. Furthermore, they indicate the promise of NM-MRI as a non-invasive method to probe the LC-NE system that has the potential to support subtyping and treatment of PTSD or other neuropsychiatric conditions.

Read the full article
Report a problem with this article

Related articles

  • More for Researchers

    Identifying opioid relapse during COVID-19 using natural language processing of nationwide Veterans Health Administration electronic medical record data

    Abstract: Novel and automated means of opioid use and relapse risk detection are needed. Unstructured electronic medical record data, including written progress notes, can be mined for clinically relevant information, including the presence of substance use and relapse-critical markers of risk and recovery from opioid use disorder (OUD). In this study, we used natural language processing (NLP) to automate the extraction of opioid relapses, and the timing of these occurrences, from veteran patients' electronic medical record. We then demonstrated the utility of our NLP tool via analysis of pre-/post-COVID-19 opioid relapse trends among veterans with OUD. For this demonstration, we analyzed data from 107,606 veterans OUD enrolled in Veterans Health Administration, comparing a pandemic-exposed cohort (n = 53,803; January 2019-March 2021) to a matched prepandemic cohort (n = 53,803; October 2017-December 2019). The recall of our NLP tool was 75% and our precision was 94%, demonstrating moderate sensitivity and excellent specificity. Using the NLP tool, we found that the odds of opioid relapse postpandemic onset were proportionally higher compared to prepandemic trends, despite patients having fewer mental health encounters from which to derive instances of relapse postpandemic onset. In this research application of the tool, and as hypothesized, we found that opioid relapse risk was elevated postpandemic. The application of NLP Methods: to identify and monitor relapse risk holds promise for future surveillance, risk prevention, and clinical outcome research.